HAART: a risk factor for development of porphyria cutanea tarda?

Rev Soc Bras Med Trop. 2012 Dec;45(6):764-7. doi: 10.1590/s0037-86822012000600022.

Abstract

Porphyria cutanea tarda (PCT) is caused by inherited or acquired partial deficiency of the uroporphyrinogen-decarboxylase (Uro-D) enzyme activity. It is the most common form of porphyria. The main triggering factors to the development of porphyria cutanea tarda are alcohol, hepatitis C virus and human immunodeficiency virus. There are several reports of PCT associated with drugs, among them, antiretroviral therapy. We describe three HIV-positive patients, which showed photosensitivity as well as the emergence of tense blisters on sun-exposed areas during the use of highly active antiretroviral therapy (HAART) and discuss the possibility of PCT after the use of these drugs by those patients.

Publication types

  • Case Reports

MeSH terms

  • Antiretroviral Therapy, Highly Active / adverse effects*
  • HIV Infections / drug therapy
  • Humans
  • Male
  • Middle Aged
  • Porphyria Cutanea Tarda / chemically induced*
  • Porphyria Cutanea Tarda / diagnosis
  • Risk Factors